1. Home
  2. MDT

as of 07-23-2026 3:46pm EST

$82.06
+$0.17
+0.20%
Stocks Health Care Biotechnology: Electromedical & Electrotherapeutic Apparatus Nasdaq

One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.

Founded: 1949 Country:
Ireland
Ireland
Employees: N/A City: GALWAY
Market Cap: 107.0B IPO Year: 2014
Target Price: $108.21 AVG Volume (30 days): 8.4M
Analyst Decision: Buy Number of Analysts: 21
Dividend Yield:
3.58%
Dividend Payout Frequency: quarterly
EPS: 3.73 EPS Growth: 3.32
52 Week Low/High: $73.31 - $106.33 Next Earning Date: 06-03-2026
Revenue: $36,364,000,000 Revenue Growth: 8.43%
Revenue Growth (this year): 8.91% Revenue Growth (next year): 6.54%
P/E Ratio: 21.95 Index:
Free Cash Flow: 5.4B FCF Growth: -1.04%

AI-Powered MDT Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 75.69%
75.69%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Medtronic plc. (MDT)

Walter Matthew R.

SVP, Chief HR Officer

Sell
MDT Jul 8, 2026

Avg Cost/Share

$83.15

Shares

3,102

Total Value

$257,931.30

Owned After

35,694

SEC Form 4

KIIL HARRY SKIP

EVP & President Cardiovascular

Sell
MDT Jun 8, 2026

Avg Cost/Share

$80.45

Shares

4,189

Total Value

$336,965.44

Owned After

37,455

Earnings Transcripts

SEC 8-K filings with transcript text

View All
2026
Q1

Q1 2026 Earnings

8-K BUY

Jun 3, 2026 · 100% conf.

AI Prediction BUY

1D

+1.12%

$78.81

Act: +5.13%

5D

+2.20%

$79.65

Act: +2.96%

20D

+0.71%

$78.50

Act: +6.74%

Price: $77.94 Prob +5D: 100% AUC: 1.000
0001628280-26-040034

SEC.gov | Request Rate Threshold Exceeded

U.S. Securities and Exchange Commission

You’ve Exceeded the SEC’s Traffic Limit

Your request rate has exceeded the SEC’s maximum allowable requests per second. Your access to SEC.gov will be limited for 10 minutes.

Current guidelines limit each user to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests. To ensure that SEC.gov remains available to all users, we reserve the right to block IP addresses that submit excessive requests.

The block will be lifted automatically by waiting 10 minutes. Continuing to exceed the SEC’s maximum allowable request rate during the time-out period will extend the duration of the time-out period. To ensure fair access for all users, please reduce the rate of your requests and visit SEC.gov again after the 10 minute time-out period has passed.

For best practices on efficiently downloading information from SEC.gov, including the latest EDGAR filings, visit sec.gov/developer. You can also sign up for email updates on the SEC open data program, including best practices that make it more efficient to download data, and SEC.gov enhancements that may impact scripted downloading processes. For more information, contact opendata@sec.gov.

For more information, please see the SEC’s Web Site Privacy and Security Policy. Thank you for your interest in the U.S. Securities and Exchange Commission.

Reference ID: 0.e618d017.1784726344.7f4861d

More Information

Internet Security Policy

By using this site, you are agreeing to security monitoring and auditing. For security purposes, and to ensure that the public service remains available to users, this government computer system employs programs to monitor network traffic to identify unauthorized attempts to upload or change information or to otherwise cause damage, including attempts to deny service to users.

Unauthorized attempts to upload information and/or change information on any portion of this site are strictly prohibited and are subject to prosecution under the Computer Fraud and Abuse Act of 1986 and the National Information Infrastructure Protection Act of 1996 (see Title 18 U.S.C. §§ 1001 and 1030).

To ensure our website performs well for all users, the SEC monitors the frequency of requests for SEC.gov content to ensure automated searches do not impact the ability of others to access SEC.gov content. We reserve the right to block IP addresses that submit excessive requests. Current guidelines limit users to a total of no more than 10 requests per second, regardless of the number of machines used to submit requests.

If a user or application submits more than 10 requests per second, further requests from the IP address(es) may be limited for a brief period. Once the rate of requests has dropped below the threshold for 10 minutes, the user may resume accessing content on SEC.gov. This SEC practice is designed to limit excessive automated searches on SEC.gov and is not intended or expected to impact individuals browsing the SEC.gov website.

Note that this policy may change as the SEC manages SEC.gov to ensure that the website performs efficiently and remains available to all users.

Note: We do not offer technical support for developing or debugging scripted downloading processes.

2025
Q4

Q4 2025 Earnings

8-K SELL

Feb 17, 2026 · 96% conf.

AI Prediction SELL

1D

-1.75%

$94.73

Act: +2.16%

5D

-2.26%

$94.23

Act: +0.35%

20D

-1.38%

$95.08

Price: $96.41 Prob +5D: 2% AUC: 1.000
0001628280-26-008300

mdt-202602170001613103H91 VY19false00016131032026-02-172026-02-170001613103mdt:A1.125SeniorNotesDue2027Member2026-02-172026-02-170001613103mdt:A0.375SeniorNotesDue2028Member2026-02-172026-02-170001613103mdt:A3.000SeniorNotesDue2028Member2026-02-172026-02-170001613103mdt:A3.650SeniorNotesDue2029Member2026-02-172026-02-170001613103mdt:A2.950SeniorNotesDue2030Member2026-02-172026-02-170001613103mdt:A1.625SeniorNotesDue2031Member2026-02-172026-02-170001613103mdt:A1.000SeniorNotesDue2031Member2026-02-172026-02-170001613103mdt:A3.125SeniorNotesDue2031Member2026-02-172026-02-170001613103mdt:A0.750SeniorNotesDue2032Member2026-02-172026-02-170001613103mdt:A3.375SeniorNotesDue2034Member2026-02-172026-02-170001613103mdt:A3.875SeniorNotesDue2036Member2026-02-172026-02-170001613103mdt:A2.250SeniorNotesDue2039Member2026-02-172026-02-170001613103mdt:A1.500SeniorNotesDue2039Member2026-02-172026-02-170001613103mdt:A1.375SeniorNotesDue2040Member2026-02-172026-02-170001613103mdt:A4.150SeniorNotesDue2043Member2026-02-172026-02-170001613103mdt:A4.200SeniorNotesDue2045Member2026-02-172026-02-170001613103mdt:A1.750SeniorNotesDue2049Member2026-02-172026-02-170001613103mdt:A1.625SeniorNotesDue2050Member2026-02-172026-02-170001613103mdt:A4.150SeniorNotesDue2053Member2026-02-172026-02-17

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 17, 2026


Medtronic plc (Exact name of Registrant as Specified in its Charter)


Ireland 1-36820 98-1183488 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

Building Two Parkmore Business Park West Galway, Ireland (Address of principal executive offices) (Zip Code) +353 1 438-1700 (Registrant’s telephone number, including area code)

Not Applicable Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading SymbolName of each exchange on which registered Ordinary shares, par value $0.0001 per shareMDTNew York Stock Exchange 1.125% Senior Notes due 2027MDT/27New York Stock Exchange 0.375% Senior Notes due 2028MDT/28New York Stock Exchange 3.000% Senior Notes due 2028MDT/28ANew York Stock Exchange 3.650% Senior Notes due 2029MDT/29New York Stock Exchange 2.950% Senior Notes due 2030MDT/30New York Stock Exchange 1.625% Senior Notes due 2031MDT/31New York Stock Exchange 1.000% Senior Notes due 2031MDT/31ANew York Stock Exchange 3.125% Senior Notes due 2031MDT/31BNew York Stock Exchange 0.750% Senior Notes due 2032MDT/32New York Stock Exchange 3.375% Senior Notes due 2034MDT/34New York Stock Exchange 3.875% Senior Notes due 2036MDT/36New York Stock Exchange 2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange 1.500% Senior Notes due 2039MDT/39BNew York Stock Exchange 1.375% Senior Notes due 2040MDT/40ANew York Stock Exchange 4.150% Senior Notes due 2043MDT/43ANew York Stock Exchange 4.200% Senior Notes due 2045MDT/45New York Stock Exchange 1.750% Senior Notes due 2049MDT/49New York Stock Exchange 1.625% Senior Notes due 2050MDT/50New York Stock Exchange 4.150% Senior Notes due 2053MDT/53New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02.Results of Operations and Financial Condition

On February 17, 2026, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its third quarter fiscal year 2026 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.

Item 9.01.Exhibits.

(d) List of Exhibits Exhibit Number  Description

99.1 Press release of Medtronic plc, dated February 17, 2026

104Cover Page Interactive Data File (embedded with th

2025
Q3

Q3 2025 Earnings

8-K

Nov 18, 2025

0001628280-25-052771

mdt-202511180001613103H91 VY19false00016131032025-11-182025-11-180001613103mdt:A1.125SeniorNotesDue2027Member2025-11-182025-11-180001613103mdt:A0.375SeniorNotesDue2028Member2025-11-182025-11-180001613103mdt:A3.000SeniorNotesDue2028Member2025-11-182025-11-180001613103mdt:A3.650SeniorNotesDue2029Member2025-11-182025-11-180001613103mdt:A2.950SeniorNotesDue2030Member2025-11-182025-11-180001613103mdt:A1.625SeniorNotesDue2031Member2025-11-182025-11-180001613103mdt:A1.000SeniorNotesDue2031Member2025-11-182025-11-180001613103mdt:A3.125SeniorNotesDue2031Member2025-11-182025-11-180001613103mdt:A0.750SeniorNotesDue2032Member2025-11-182025-11-180001613103mdt:A3.375SeniorNotesDue2034Member2025-11-182025-11-180001613103mdt:A3.875SeniorNotesDue2036Member2025-11-182025-11-180001613103mdt:A2.250SeniorNotesDue2039Member2025-11-182025-11-180001613103mdt:A1.500SeniorNotesDue2039Member2025-11-182025-11-180001613103mdt:A1.375SeniorNotesDue2040Member2025-11-182025-11-180001613103mdt:A4.150SeniorNotesDue2043Member2025-11-182025-11-180001613103mdt:A4.200SeniorNotesDue2045Member2025-11-182025-11-180001613103mdt:A1.750SeniorNotesDue2049Member2025-11-182025-11-180001613103mdt:A1.625SeniorNotesDue2050Member2025-11-182025-11-180001613103mdt:A4.150SeniorNotesDue2053Member2025-11-182025-11-18

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 8-K


CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 18, 2025


Medtronic plc (Exact name of Registrant as Specified in its Charter)


Ireland 1-36820 98-1183488 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)

Building Two Parkmore Business Park West Galway, Ireland (Address of principal executive offices) (Zip Code) +353 1 438-1700 (Registrant’s telephone number, including area code)

Not Applicable Former name or former address, if changed since last report

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading SymbolName of each exchange on which registered Ordinary shares, par value $0.0001 per shareMDTNew York Stock Exchange 1.125% Senior Notes due 2027MDT/27New York Stock Exchange 0.375% Senior Notes due 2028MDT/28New York Stock Exchange 3.000% Senior Notes due 2028MDT/28ANew York Stock Exchange 3.650% Senior Notes due 2029MDT/29New York Stock Exchange 2.950% Senior Notes due 2030MDT/30New York Stock Exchange 1.625% Senior Notes due 2031MDT/31New York Stock Exchange 1.000% Senior Notes due 2031MDT/31ANew York Stock Exchange 3.125% Senior Notes due 2031MDT/31BNew York Stock Exchange 0.750% Senior Notes due 2032MDT/32New York Stock Exchange 3.375% Senior Notes due 2034MDT/34New York Stock Exchange 3.875% Senior Notes due 2036MDT/36New York Stock Exchange 2.250% Senior Notes due 2039MDT/39ANew York Stock Exchange 1.500% Senior Notes due 2039MDT/39BNew York Stock Exchange 1.375% Senior Notes due 2040MDT/40ANew York Stock Exchange 4.150% Senior Notes due 2043MDT/43ANew York Stock Exchange 4.200% Senior Notes due 2045MDT/45New York Stock Exchange 1.750% Senior Notes due 2049MDT/49New York Stock Exchange 1.625% Senior Notes due 2050MDT/50New York Stock Exchange 4.150% Senior Notes due 2053MDT/53New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02.Results of Operations and Financial Condition

On November 18, 2025, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its second quarter fiscal year 2026 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.

Item 9.01.Exhibits.

(d) List of Exhibits Exhibit Number  Description

99.1 Press release of Medtronic plc, dated November 18, 2025

104Cover Page Interactive Data File (embedded with t

Share on Social Networks: